Raymond James Trust N.A. Corcept Therapeutics Inc Transaction History
Raymond James Trust N.A.
- $4.55 Billion
- Q3 2024
A detailed history of Raymond James Trust N.A. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Raymond James Trust N.A. holds 18,000 shares of CORT stock, worth $1.05 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
18,000
Previous 18,000
-0.0%
Holding current value
$1.05 Million
Previous $584,000
42.47%
% of portfolio
0.02%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding CORT
# of Institutions
347Shares Held
86.6MCall Options Held
1.12MPut Options Held
667K-
Black Rock Inc. New York, NY16.5MShares$969 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$586 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.27MShares$484 Million14.93% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.51MShares$381 Million0.48% of portfolio
-
Parallel Advisors, LLC3.81MShares$223 Million4.22% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $6.27B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...